logo

Intercept Pharmaceuticals Inc. (ICPT)



Trade ICPT now with
  Date
  Headline
11/16/2017 4:09:33 PM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $253 Price Target
11/1/2017 2:49:52 PM Jefferies Is Increasing Intercept Pharmaceuticals Inc. (ICPT) FY18 Rev. Estimate To -11.84 M From -11.86 M
11/1/2017 2:49:30 PM Jefferies Is Cutting Intercept Pharmaceuticals Inc. (ICPT) FY17 Rev. Estimate To 132.7 M From 135.3 M
11/1/2017 2:49:02 PM Jefferies Is Raising Intercept Pharmaceuticals Inc. (ICPT) FY18 Estimate To -12.38 From -13.48
11/1/2017 2:48:42 PM Jefferies Is Increasing Intercept Pharmaceuticals Inc. (ICPT) FY17 Estimate To -13.54 From -14.25
11/1/2017 7:11:17 AM Intercept Pharma Q3 Loss Per Share $2.89 Vs Loss $3.59 Last Year
9/15/2017 9:49:34 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Ourperform With $253 Price Target
8/25/2017 9:07:07 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $253 Price Target
8/18/2017 6:54:52 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $253 Price Target
7/31/2017 7:13:25 AM Intercept Pharma Q2 Net Loss $86.56 Mln Or $3.46/Shr Vs Loss$77.3 Mln Or $3.14/Shr Last Year
7/31/2017 7:09:22 AM Intercept Announces Positive Results From Phase 2 AESOP Trial Evaluating OCA For Primary Sclerosing Cholangitis
6/23/2017 9:37:53 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $231 Price Target
6/16/2017 11:41:53 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $231 Price Target
6/13/2017 6:54:38 AM Wedbush Is Raising Intercept Pharmaceuticals Inc. (ICPT) 2018 Estimate To -11.28 From -12.09